158 related articles for article (PubMed ID: 20160070)
1. Breast cancer patients' treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy.
Lipkus IM; Peters E; Kimmick G; Liotcheva V; Marcom P
Med Decis Making; 2010; 30(4):464-73. PubMed ID: 20160070
[TBL] [Abstract][Full Text] [Related]
2. The benefits of discussing adjuvant therapies one at a time instead of all at once.
Zikmund-Fisher BJ; Angott AM; Ubel PA
Breast Cancer Res Treat; 2011 Aug; 129(1):79-87. PubMed ID: 20945090
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.
Wong J; D'Alimonte L; Angus J; Paszat L; Metcalfe K; Whelan T; Llewellyn-Thomas H; Warner E; Franssen E; Szumacher E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):30-8. PubMed ID: 22331002
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.
Martín M; González-Rivera M; Morales S; de la Haba-Rodriguez J; González-Cortijo L; Manso L; Albanell J; González-Martín A; González S; Arcusa A; de la Cruz-Merino L; Rojo F; Vidal M; Galván P; Aguirre E; Morales C; Ferree S; Pompilio K; Casas M; Caballero R; Goicoechea U; Carrasco E; Michalopoulos S; Hornberger J; Prat A
Curr Med Res Opin; 2015 Jun; 31(6):1129-37. PubMed ID: 25851308
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.
Paridaens RJ; Gelber S; Cole BF; Gelber RD; Thürlimann B; Price KN; Holmberg SB; Crivellari D; Coates AS; Goldhirsch A
Breast Cancer Res Treat; 2010 Aug; 123(1):303-10. PubMed ID: 20195744
[TBL] [Abstract][Full Text] [Related]
7. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.
Ravdin PM; Siminoff LA; Davis GJ; Mercer MB; Hewlett J; Gerson N; Parker HL
J Clin Oncol; 2001 Feb; 19(4):980-91. PubMed ID: 11181660
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
9. Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing.
Fallowfield L; Matthews L; May S; Jenkins V; Bloomfield D
Psychooncology; 2018 Apr; 27(4):1264-1269. PubMed ID: 29448311
[TBL] [Abstract][Full Text] [Related]
10. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
[TBL] [Abstract][Full Text] [Related]
11. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.
Torres S; Trudeau M; Gandhi S; Warner E; Verma S; Pritchard KI; Petrella T; Hew-Shue M; Chao C; Eisen A
Oncologist; 2018 Jul; 23(7):768-775. PubMed ID: 29371476
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
Sanft T; Aktas B; Schroeder B; Bossuyt V; DiGiovanna M; Abu-Khalaf M; Chung G; Silber A; Hofstatter E; Mougalian S; Epstein L; Hatzis C; Schnabel C; Pusztai L
Breast Cancer Res Treat; 2015 Dec; 154(3):533-41. PubMed ID: 26578401
[TBL] [Abstract][Full Text] [Related]
15. Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.
Vickers AJ; Elkin EB; Peele PB; Dickler M; Siminoff LA
Med Decis Making; 2009; 29(4):461-7. PubMed ID: 19270108
[TBL] [Abstract][Full Text] [Related]
16. Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict.
van Steenhoven JEC; den Dekker BM; Kuijer A; van Diest PJ; Nieboer P; Zuetenhorst JM; Imholz ALT; Siesling S; van Dalen T
Breast Cancer Res Treat; 2020 Jul; 182(1):107-115. PubMed ID: 32430679
[TBL] [Abstract][Full Text] [Related]
17. Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center.
Fayaz S; Eissa HE; Demian GA
J Egypt Natl Canc Inst; 2020 Mar; 32(1):13. PubMed ID: 32372329
[TBL] [Abstract][Full Text] [Related]
18. A decision aid to assist in adjuvant therapy choices for breast cancer.
Siminoff LA; Gordon NH; Silverman P; Budd T; Ravdin PM
Psychooncology; 2006 Nov; 15(11):1001-13. PubMed ID: 16511899
[TBL] [Abstract][Full Text] [Related]
19. The overall survival of breast cancer patients without adjuvant therapy.
Onishi S; Sawaki M; Ishiguro J; Kataoka A; Iwase M; Sugino K; Adachi Y; Gondo N; Kotani H; Yoshimura A; Hattori M; Matsuo K; Yatabe Y; Iwata H
Surg Today; 2019 Jul; 49(7):610-620. PubMed ID: 30730005
[TBL] [Abstract][Full Text] [Related]
20. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
